Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial F.J. Melgosa-Ramos; A. Vicente Villa; I. Betlloch Mas; S. Santos-Alarcón;

Inhibidores de JAK en dermatitis atópica, nuevas perspectivas M. Munera-Campos; J.M. Carrascosa;

[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives M. Munera-Campos; J.M. Carrascosa;